Biotechnology Archives - RamaOnHealthcare

Pharma / Biotech: Biotechnology

Read recent healthcare news on biotechnology in healthcare. Stay current on trends with our daily newsletter. Also, research insights with our curated search portal.

Treatment for all: the key steps to better representation in pharma

2021-09-27T21:24:32-04:00

pharmaphorum September 27, 2021

Treatment for all: the key steps to better representation in pharma2021-09-27T21:24:32-04:00

Biosimilars Gain Traction with Regulators, Manufacturers

2021-09-27T21:23:11-04:00

Pharmaceutical Executive September 27, 2021

Biosimilars Gain Traction with Regulators, Manufacturers2021-09-27T21:23:11-04:00

The pandemic problems that boosters won’t solve

2021-09-27T21:21:37-04:00

MIT Technology Review September 27, 2021

The pandemic problems that boosters won’t solve2021-09-27T21:21:37-04:00

In-home care positioned to play a key role in the consumerization of healthcare [Sponsored]

2021-09-27T21:19:18-04:00

MedCity News September 27, 2021

In-home care positioned to play a key role in the consumerization of healthcare [Sponsored]2021-09-27T21:19:18-04:00

How private funding is blurring the peer-review lines in medical research

2021-09-27T21:07:15-04:00

Fast Company September 27, 2021

How private funding is blurring the peer-review lines in medical research2021-09-27T21:07:15-04:00

Can We Tik-Tok Our Way Out of a Pandemic? A Q&A about Gen Z Influencers, and Where Pharma Can Go Next

2021-09-27T20:17:25-04:00

Pharmaceutical Executive September 27, 2021

Can We Tik-Tok Our Way Out of a Pandemic? A Q&A about Gen Z Influencers, and Where Pharma Can Go Next2021-09-27T20:17:25-04:00

Setting Sights on the COVID Vaccine Market: Shankar Musunuri, CEO, Ocugen

2021-09-27T20:16:17-04:00

Pharmaceutical Executive September 27, 2021

Setting Sights on the COVID Vaccine Market: Shankar Musunuri, CEO, Ocugen2021-09-27T20:16:17-04:00

Psychedelic drugs, but safer: Delix raises $70M to bring new neuro meds to clinic

2021-09-27T18:28:47-04:00

MedCity News September 27, 2021

Psychedelic drugs, but safer: Delix raises $70M to bring new neuro meds to clinic2021-09-27T18:28:47-04:00

2021 Lasker Awards Honor Neuroscience Researchers, A Biomedical Legend And mRNA Vaccine Pioneers

2021-09-26T22:43:23-04:00

Forbes September 24, 2021

2021 Lasker Awards Honor Neuroscience Researchers, A Biomedical Legend And mRNA Vaccine Pioneers2021-09-26T22:43:23-04:00

The Blueprints of Health

2021-09-26T22:34:08-04:00

Scientific American September 24, 2021

The Blueprints of Health2021-09-26T22:34:08-04:00

Life sciences use of digital twins mirrors its application in other industries

2021-09-26T22:07:16-04:00

MedCity News September 24, 2021

Life sciences use of digital twins mirrors its application in other industries2021-09-26T22:07:16-04:00

Verily may be looking to part ways with Google’s tech

2021-09-26T22:06:18-04:00

MobiHealth News September 24, 2021

Verily may be looking to part ways with Google’s tech2021-09-26T22:06:18-04:00

Generic drug companies want to help make the COVID-19 vaccines

2021-09-24T21:53:53-04:00

AXIOS September 24, 2021

Generic drug companies want to help make the COVID-19 vaccines2021-09-24T21:53:53-04:00

Cerner joins $135M funding round for Elligo Health Research

2021-09-26T21:46:14-04:00

MedCity News September 24, 2021

Cerner joins $135M funding round for Elligo Health Research2021-09-26T21:46:14-04:00

Patient-Focused Drug Development Is An Iterative Process: Gilead’s Response To Dickson And Killelea

2021-09-26T20:08:19-04:00

Health Affairs September 24, 2021

Patient-Focused Drug Development Is An Iterative Process: Gilead’s Response To Dickson And Killelea2021-09-26T20:08:19-04:00

Physicians hesitant to switch patients from biologics to biosimilar drugs, report finds

2021-09-23T21:48:34-04:00

Becker's Healthcare September 23, 2021

Physicians hesitant to switch patients from biologics to biosimilar drugs, report finds2021-09-23T21:48:34-04:00

Aiming for better genetic medicines delivery, startup GenEdit grabs $26M

2021-09-23T20:02:09-04:00

MedCity News September 23, 2021

Aiming for better genetic medicines delivery, startup GenEdit grabs $26M2021-09-23T20:02:09-04:00

Biosimilar Drugs Are Cheaper Than Biologics. Are They Similar Enough to Switch?

2021-09-23T16:52:03-04:00

California Healthline September 23, 2021

Biosimilar Drugs Are Cheaper Than Biologics. Are They Similar Enough to Switch?2021-09-23T16:52:03-04:00

Novartis expands gene therapy pipeline with Arctos Medical takeover

2021-09-23T15:48:11-04:00

PharmaTimes September 23, 2021

Novartis expands gene therapy pipeline with Arctos Medical takeover2021-09-23T15:48:11-04:00

Opinion: The brain health paradox: Dementia rates have fallen even as drugs have failed

2021-09-23T15:44:08-04:00

STAT September 23, 2021

Opinion: The brain health paradox: Dementia rates have fallen even as drugs have failed2021-09-23T15:44:08-04:00

Google sister company Verily looking to break free, with potential for IPO, telehealth push

2021-09-23T15:30:01-04:00

Becker's Healthcare September 23, 2021

Google sister company Verily looking to break free, with potential for IPO, telehealth push2021-09-23T15:30:01-04:00

A Pandemic-Driven Digital Transformation: What Will Stick for Life Sciences

2021-09-23T15:28:25-04:00

Bio-IT World September 23, 2021

A Pandemic-Driven Digital Transformation: What Will Stick for Life Sciences2021-09-23T15:28:25-04:00

AstraZeneca strikes deal with university spinoff to turn RNA into drugs

2021-09-23T15:24:44-04:00

BioPharma Dive September 23, 2021

AstraZeneca strikes deal with university spinoff to turn RNA into drugs2021-09-23T15:24:44-04:00

Moderna chief sees pandemic lasting another year

2021-09-23T14:58:14-04:00

Hill September 23, 2021

Moderna chief sees pandemic lasting another year2021-09-23T14:58:14-04:00